In this special episode of the View, Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss Day 1 of ESC Congress 2019, including objective risk assessment versus standard care for acute coronary syndromes (AGRIS); the relationship between hypoglycemia, cardiovascular outcomes, and empagliflozin treatment (EMPA-REG OUTCOME); and maximum-fixed energy versus low-escalating energy shocks for cardioversion of atrial fibrillation (CHESS).

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, Arrhythmias and Clinical EP, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Implantable Devices, EP Basic Science, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Interventions and ACS, Interventions and Imaging, Angiography, Nuclear Imaging

Keywords: EaglesEyeView, ESC Congress, ESC 19, Arrhythmias, Cardiac, Arrhythmia, Sinus, Atrial Fibrillation, Burns, Electric, Electric Countershock, Myocardium, Pain, Secondary Prevention, Shock, Acute Coronary Syndrome, Angina, Unstable, Angiotensin Receptor Antagonists, Aspirin, Cardiac Rehabilitation, Cardiology Interventions, Coronary Angiography, Heart Failure, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medical Futility, Medication Adherence, Myocardial Infarction, Risk Factors, Secondary Prevention, Standard of Care, Diabetes Mellitus, Type 2, Glucose, Heart Failure, Glycated Hemoglobin A, Hyperglycemia, Hypoglycemic Agents, Insulin, Kidney Diseases, Metabolic Syndrome, Metformin, Myocardial Infarction, Primary Prevention, Stroke, Sulfonylurea Compounds

< Back to Listings